Page last updated: 2024-10-24

chloroquine and Cleidocranial Digital Dysostosis

chloroquine has been researched along with Cleidocranial Digital Dysostosis in 1 studies

Chloroquine: The prototypical antimalarial agent with a mechanism that is not well understood. It has also been used to treat rheumatoid arthritis, systemic lupus erythematosus, and in the systemic therapy of amebic liver abscesses.
chloroquine : An aminoquinoline that is quinoline which is substituted at position 4 by a [5-(diethylamino)pentan-2-yl]amino group at at position 7 by chlorine. It is used for the treatment of malaria, hepatic amoebiasis, lupus erythematosus, light-sensitive skin eruptions, and rheumatoid arthritis.

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Lenk, GM	3
Meisler, MH	3

Other Studies

1 other study available for chloroquine and Cleidocranial Digital Dysostosis

Article	Year
Chloroquine corrects enlarged lysosomes in FIG4 null cells and reduces neurodegeneration in Fig4 null mice. Molecular genetics and metabolism, 2022, Volume: 137, Issue:4 Topics: Animals; Chloroquine; Cleidocranial Dysplasia; Flavoproteins; Lymphocytes, Null; Lysosomes; Mice; Mi	2022
Chloroquine corrects enlarged lysosomes in FIG4 null cells and reduces neurodegeneration in Fig4 null mice. Molecular genetics and metabolism, 2022, Volume: 137, Issue:4 Topics: Animals; Chloroquine; Cleidocranial Dysplasia; Flavoproteins; Lymphocytes, Null; Lysosomes; Mice; Mi	2022
Chloroquine corrects enlarged lysosomes in FIG4 null cells and reduces neurodegeneration in Fig4 null mice. Molecular genetics and metabolism, 2022, Volume: 137, Issue:4 Topics: Animals; Chloroquine; Cleidocranial Dysplasia; Flavoproteins; Lymphocytes, Null; Lysosomes; Mice; Mi	2022
Chloroquine corrects enlarged lysosomes in FIG4 null cells and reduces neurodegeneration in Fig4 null mice. Molecular genetics and metabolism, 2022, Volume: 137, Issue:4 Topics: Animals; Chloroquine; Cleidocranial Dysplasia; Flavoproteins; Lymphocytes, Null; Lysosomes; Mice; Mi	2022
Chloroquine corrects enlarged lysosomes in FIG4 null cells and reduces neurodegeneration in Fig4 null mice. Molecular genetics and metabolism, 2022, Volume: 137, Issue:4 Topics: Animals; Chloroquine; Cleidocranial Dysplasia; Flavoproteins; Lymphocytes, Null; Lysosomes; Mice; Mi	2022
Chloroquine corrects enlarged lysosomes in FIG4 null cells and reduces neurodegeneration in Fig4 null mice. Molecular genetics and metabolism, 2022, Volume: 137, Issue:4 Topics: Animals; Chloroquine; Cleidocranial Dysplasia; Flavoproteins; Lymphocytes, Null; Lysosomes; Mice; Mi	2022
Chloroquine corrects enlarged lysosomes in FIG4 null cells and reduces neurodegeneration in Fig4 null mice. Molecular genetics and metabolism, 2022, Volume: 137, Issue:4 Topics: Animals; Chloroquine; Cleidocranial Dysplasia; Flavoproteins; Lymphocytes, Null; Lysosomes; Mice; Mi	2022
Chloroquine corrects enlarged lysosomes in FIG4 null cells and reduces neurodegeneration in Fig4 null mice. Molecular genetics and metabolism, 2022, Volume: 137, Issue:4 Topics: Animals; Chloroquine; Cleidocranial Dysplasia; Flavoproteins; Lymphocytes, Null; Lysosomes; Mice; Mi	2022
Chloroquine corrects enlarged lysosomes in FIG4 null cells and reduces neurodegeneration in Fig4 null mice. Molecular genetics and metabolism, 2022, Volume: 137, Issue:4 Topics: Animals; Chloroquine; Cleidocranial Dysplasia; Flavoproteins; Lymphocytes, Null; Lysosomes; Mice; Mi	2022